Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pediatr Hematol Oncol ; 41(6): 448-451, 2019 08.
Artigo em Inglês | MEDLINE | ID: mdl-30676437

RESUMO

Cancer treatments are associated with short and long-effects. Epidemiological reports have revealed clinical features of metabolic syndrome (MS), obesity or overweight in young cancer survivors. The aim of the study was to examine the prevalence of unhealthy weight status and risk factors associated with MS related to chemotherapy. We study 52 pediatric cancer patients and analyze cholesterol, triglycerides, glycosylated hemoglobin, body mass index, waist circumference (WC), FINDRISC test. All the parameters were analyzed according to the percentile corresponding to sex and age of each child. The data show an important modification in weight, body mass index, and WC as in triglycerides, and cholesterol that could be associated with the development of MS. The variance analysis showed that the WC, triglycerides, and cholesterol are statistically correlated in our population. A follow-up for MS in children cancer survivor should be considered necessary.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Índice de Massa Corporal , Síndrome Metabólica/epidemiologia , Neoplasias/tratamento farmacológico , Obesidade/epidemiologia , Sobrepeso/epidemiologia , Glicemia/metabolismo , Criança , Colesterol/metabolismo , Feminino , Seguimentos , Humanos , Masculino , Síndrome Metabólica/induzido quimicamente , Síndrome Metabólica/metabolismo , México/epidemiologia , Neoplasias/patologia , Obesidade/induzido quimicamente , Obesidade/metabolismo , Sobrepeso/induzido quimicamente , Sobrepeso/metabolismo , Prevalência , Prognóstico , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...